{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T12:00:50Z","timestamp":1762430450454,"version":"3.40.3"},"reference-count":59,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,8,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Chemokines are key regulators of leukocyte trafficking and play a crucial role under homeostatic and inflammatory conditions. Because chemokines are involved in multiple pathologies, they represent an attractive class of therapeutic targets. However, because of the redundancy of this system, neutralizing a single chemokine may be insufficient to achieve therapeutic benefit. Our strategy was to use a Fc-fusion recombinant protein form of the poxvirus-derived viral CC chemokine inhibitor protein (vCCI-Fc) that has the ability to specifically bind to multiple CC chemokines and neutralize their activity. In this study, we demonstrate first that, in vivo, vCCI-Fc prevents CC chemokine-dependent migration of macrophages into inflamed tissue of carageenan-challenged mice. We next studied this effect of inhibiting CC chemokine activity in a model more relevant to human disease, collagen-induced arthritis. Mice receiving vCCI-Fc revealed a striking retention of splenocytes, including activated and IFN-\u03b3\u2013secreting CD4+ and CD8+ T cells, that was associated with a concomitant decrease of cells in the draining lymph nodes. These phenomena resulted in a significant decrease in the incidence of disease and a reduction in clinical score, joint inflammation, and cartilage destruction as compared with mice receiving isotype control. Taken together, these results define a role for CC chemokines in the control of disease, as interfering with their function leads to a previously unappreciated role of controlling inflammatory cell trafficking in and out of secondary lymphoid organs.<\/jats:p>","DOI":"10.4049\/jimmunol.1000182","type":"journal-article","created":{"date-parts":[[2010,7,19]],"date-time":"2010-07-19T22:27:24Z","timestamp":1279578444000},"page":"2544-2554","source":"Crossref","is-referenced-by-count":21,"title":["Pan\u2013CC Chemokine Neutralization Restricts Splenocyte Egress and Reduces Inflammation in a Model of Arthritis"],"prefix":"10.1093","volume":"185","author":[{"given":"Vanessa","family":"Buatois","sequence":"first","affiliation":[{"name":"NovImmune SA , Geneva ,","place":["Switzerland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00e9verine","family":"Fag\u00e8te","sequence":"additional","affiliation":[{"name":"NovImmune SA , Geneva ,","place":["Switzerland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Magistrelli","sequence":"additional","affiliation":[{"name":"NovImmune SA , Geneva ,","place":["Switzerland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurence","family":"Chatel","sequence":"additional","affiliation":[{"name":"NovImmune SA , Geneva ,","place":["Switzerland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Fischer","sequence":"additional","affiliation":[{"name":"NovImmune SA , Geneva ,","place":["Switzerland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie H","family":"Kosco-Vilbois","sequence":"additional","affiliation":[{"name":"NovImmune SA , Geneva ,","place":["Switzerland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter G","family":"Ferlin","sequence":"additional","affiliation":[{"name":"NovImmune SA , Geneva ,","place":["Switzerland"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2010,8,15]]},"reference":[{"key":"2025032411481937500_r1","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1056\/NEJM199802123380706","article-title":"Chemokines: chemotactic cytokines that mediate inflammation","volume":"338","author":"Luster","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"2025032411481937500_r2","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1146\/annurev.immunol.24.021605.090529","article-title":"Chemokine: receptor structure, interactions, and antagonism","volume":"25","author":"Allen","year":"2007","journal-title":"Annu. Rev. Immunol."},{"key":"2025032411481937500_r3","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/33340","article-title":"Chemokines and leukocyte traffic","volume":"392","author":"Baggiolini","year":"1998","journal-title":"Nature"},{"key":"2025032411481937500_r4","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1074-7613(00)80165-X","article-title":"Chemokines: a new classification system and their role in immunity","volume":"12","author":"Zlotnik","year":"2000","journal-title":"Immunity"},{"key":"2025032411481937500_r5","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1146\/annurev.immunol.22.012703.104543","article-title":"Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells","volume":"22","author":"Rot","year":"2004","journal-title":"Annu. Rev. Immunol."},{"key":"2025032411481937500_r6","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/84209","article-title":"Chemokines and disease","volume":"2","author":"Gerard","year":"2001","journal-title":"Nat. Immunol."},{"key":"2025032411481937500_r7","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1177\/039463200702000303","article-title":"Anti-chemokine therapy for inflammatory diseases","volume":"20","author":"Castellani","year":"2007","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"2025032411481937500_r8","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.tips.2005.11.001","article-title":"Chemokine blockers: therapeutics in the making?","volume":"27","author":"Wells","year":"2006","journal-title":"Trends Pharmacol. Sci."},{"key":"2025032411481937500_r9","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/0167-5699(95)80030-1","article-title":"Cytokine receptors encoded by poxviruses: a lesson in cytokine biology","volume":"16","author":"Alcam\u00ed","year":"1995","journal-title":"Immunol. Today"},{"key":"2025032411481937500_r10","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nri980","article-title":"Viral mimicry of cytokines, chemokines and their receptors","volume":"3","author":"Alcami","year":"2003","journal-title":"Nat. Rev. Immunol."},{"key":"2025032411481937500_r11","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.cytogfr.2004.12.002","article-title":"Viral chemokine-modulatory proteins: tools and targets","volume":"16","author":"Boomker","year":"2005","journal-title":"Cytokine Growth Factor Rev."},{"key":"2025032411481937500_r12","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1074\/jbc.M109884200","article-title":"Comprehensive mapping of poxvirus vCCI chemokine-binding protein: expanded range of ligand interactions and unusual dissociation kinetics","volume":"277","author":"Burns","year":"2002","journal-title":"J. Biol. Chem."},{"key":"2025032411481937500_r13","doi-asserted-by":"crossref","first-page":"624","DOI":"10.4049\/jimmunol.160.2.624","article-title":"Blockade of chemokine activity by a soluble chemokine binding protein from vaccinia virus","volume":"160","author":"Alcam\u00ed","year":"1998","journal-title":"J. Immunol."},{"key":"2025032411481937500_r14","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1006\/viro.1997.8730","article-title":"Poxvirus genomes encode a secreted, soluble protein that preferentially inhibits \u03b2 chemokine activity yet lacks sequence homology to known chemokine receptors","volume":"236","author":"Smith","year":"1997","journal-title":"Virology"},{"key":"2025032411481937500_r15","doi-asserted-by":"crossref","first-page":"3418","DOI":"10.4049\/jimmunol.165.6.3418","article-title":"Local blockade of allergic airway hyperreactivity and inflammation by the poxvirus-derived pan-CC-chemokine inhibitor vCCI","volume":"165","author":"Dabbagh","year":"2000","journal-title":"J. Immunol."},{"key":"2025032411481937500_r16","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1161\/01.CIR.0000145122.58420.CO","article-title":"Broad-spectrum CC-chemokine blockade by gene transfer inhibits macrophage recruitment and atherosclerotic plaque formation in apolipoprotein E-knockout mice","volume":"110","author":"Bursill","year":"2004","journal-title":"Circulation"},{"key":"2025032411481937500_r17","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/283666a0","article-title":"Immunisation against heterologous type II collagen induces arthritis in mice","volume":"283","author":"Courtenay","year":"1980","journal-title":"Nature"},{"key":"2025032411481937500_r18","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1084\/jem.146.3.857","article-title":"Autoimmunity to type II collagen an experimental model of arthritis","volume":"146","author":"Trentham","year":"1977","journal-title":"J. Exp. Med."},{"key":"2025032411481937500_r19","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/BOR.0b013e32805e87e0","article-title":"The role of T cells in rheumatoid arthritis: new subsets and new targets","volume":"19","author":"Toh","year":"2007","journal-title":"Curr. Opin. Rheumatol."},{"key":"2025032411481937500_r20","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/jlb.59.1.6","article-title":"The role of chemokines in inflammatory joint disease","volume":"59","author":"Kunkel","year":"1996","journal-title":"J. Leukoc. Biol."},{"key":"2025032411481937500_r21","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S1044-5323(02)00124-0","article-title":"Chemokines and chemokine receptors in rheumatoid arthritis","volume":"15","author":"Szekanecz","year":"2003","journal-title":"Semin. Immunol."},{"key":"2025032411481937500_r22","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1365-2249.1994.tb06109.x","article-title":"Expression of the chemokine superfamily in rheumatoid arthritis","volume":"97","author":"Hosaka","year":"1994","journal-title":"Clin. Exp. Immunol."},{"key":"2025032411481937500_r23","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1172\/JCI115950","article-title":"Enhanced production of monocyte chemoattractant protein-1 in rheumatoid arthritis","volume":"90","author":"Koch","year":"1992","journal-title":"J. Clin. Invest."},{"key":"2025032411481937500_r24","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1172\/JCI117097","article-title":"Macrophage inflammatory protein-1\u03b1: a novel chemotactic cytokine for macrophages in rheumatoid arthritis","volume":"93","author":"Koch","year":"1994","journal-title":"J. Clin. Invest."},{"key":"2025032411481937500_r25","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1006\/clim.2000.4957","article-title":"CXCR3 and CCR5 ligands in rheumatoid arthritis synovium","volume":"98","author":"Patel","year":"2001","journal-title":"Clin. Immunol."},{"key":"2025032411481937500_r26","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1172\/JCI2172","article-title":"Polyclonal antibody directed against human RANTES ameliorates disease in the Lewis rat adjuvant-induced arthritis model","volume":"101","author":"Barnes","year":"1998","journal-title":"J. Clin. Invest."},{"key":"2025032411481937500_r27","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1002\/1529-0131(200006)43:6<1266::AID-ANR9>3.0.CO;2-P","article-title":"Temporal expression of inflammatory cytokines and chemokines in rat adjuvant-induced arthritis","volume":"43","author":"Szekanecz","year":"2000","journal-title":"Arthritis Rheum."},{"key":"2025032411481937500_r28","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1002\/1529-0131(199905)42:5<981::AID-ANR17>3.0.CO;2-4","article-title":"Predominance of mononuclear cells expressing the chemokine receptor CCR5 in synovial effusions of patients with different forms of arthritis","volume":"42","author":"Mack","year":"1999","journal-title":"Arthritis Rheum."},{"key":"2025032411481937500_r29","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/(SICI)1096-9896(199705)182:1<106::AID-PATH816>3.0.CO;2-A","article-title":"The role of monocyte chemoattractant protein-1 (MCP-1) in the pathogenesis of collagen-induced arthritis in rats","volume":"182","author":"Ogata","year":"1997","journal-title":"J. Pathol."},{"key":"2025032411481937500_r30","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.4049\/jimmunol.180.5.3447","article-title":"Inhibition of monocyte chemoattractant protein-1 ameliorates rat adjuvant-induced arthritis","volume":"180","author":"Shahrara","year":"2008","journal-title":"J. Immunol."},{"key":"2025032411481937500_r31","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1002\/1521-4141(200208)32:8<2124::AID-IMMU2124>3.0.CO;2-S","article-title":"A non-peptide CCR5 antagonist inhibits collagen-induced arthritis by modulating T cell migration without affecting anti-collagen T cell responses","volume":"32","author":"Yang","year":"2002","journal-title":"Eur. J. Immunol."},{"key":"2025032411481937500_r32","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.4049\/jimmunol.0900523","article-title":"An engineered GM-CSF-CCL2 fusokine is a potent inhibitor of CCR2-driven inflammation as demonstrated in a murine model of inflammatory arthritis","volume":"183","author":"Rafei","year":"2009","journal-title":"J. Immunol."},{"key":"2025032411481937500_r33","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.bbrc.2005.06.091","article-title":"Chemokines derived from soluble fusion proteins expressed in Escherichia coli are biologically active","volume":"334","author":"Magistrelli","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2025032411481937500_r34","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S1074-7613(00)80334-9","article-title":"Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment","volume":"6","author":"Romano","year":"1997","journal-title":"Immunity"},{"key":"2025032411481937500_r35","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1006\/viro.1998.9340","article-title":"Functional comparisons among members of the poxvirus T1\/35kDa family of soluble CC-chemokine inhibitor glycoproteins","volume":"250","author":"Lalani","year":"1998","journal-title":"Virology"},{"key":"2025032411481937500_r36","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1189\/jlb.72.1.24","article-title":"Viral chemokine-binding proteins","volume":"72","author":"Seet","year":"2002","journal-title":"J. Leukoc. Biol."},{"key":"2025032411481937500_r37","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1078\/0171-2985-00228","article-title":"Adenoviral-mediated delivery of a viral chemokine binding protein blocks CC-chemokine activity in vitro and in vivo","volume":"207","author":"Bursill","year":"2003","journal-title":"Immunobiology"},{"key":"2025032411481937500_r38","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1084\/jem.184.3.799","article-title":"Chemokine receptors and T cell chemotaxis","volume":"184","author":"Mackay","year":"1996","journal-title":"J. Exp. Med."},{"key":"2025032411481937500_r39","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.it.2003.12.005","article-title":"Chemokines: multiple levels of leukocyte migration control","volume":"25","author":"Moser","year":"2004","journal-title":"Trends Immunol."},{"key":"2025032411481937500_r40","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1182\/blood.V90.3.909","article-title":"Chemokines","volume":"90","author":"Rollins","year":"1997","journal-title":"Blood"},{"key":"2025032411481937500_r41","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nri2094","article-title":"Cytokines in the pathogenesis of rheumatoid arthritis","volume":"7","author":"McInnes","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"2025032411481937500_r42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pathophys.2005.11.001","article-title":"Chemokines and leukocyte trafficking in rheumatoid arthritis","volume":"13","author":"Tarrant","year":"2006","journal-title":"Pathophysiology"},{"key":"2025032411481937500_r43","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1196\/annals.1422.033","article-title":"The immunology of rheumatoid arthritis","volume":"1108","author":"Scrivo","year":"2007","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"2025032411481937500_r44","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1093\/rheumatology\/kem261","article-title":"Monitoring patients treated with anti-TNF-\u03b1 biopharmaceuticals: assessing serum infliximab and anti-infliximab antibodies","volume":"46","author":"Svenson","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"2025032411481937500_r45","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/art.1780360605","article-title":"Expression of monocyte chemotactic and activating factor in rheumatoid arthritis: regulation of its production in synovial cells by interleukin-1 and tumor necrosis factor","volume":"36","author":"Akahoshi","year":"1993","journal-title":"Arthritis Rheum."},{"key":"2025032411481937500_r46","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1146\/annurev.immunol.23.021704.115628","article-title":"Chemokines, sphingosine-1-phosphate, and cell migration in secondary lymphoid organs","volume":"23","author":"Cyster","year":"2005","journal-title":"Annu. Rev. Immunol."},{"key":"2025032411481937500_r47","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1146\/annurev.immunol.18.1.593","article-title":"The role of chemokine receptors in primary, effector, and memory immune responses","volume":"18","author":"Sallusto","year":"2000","journal-title":"Annu. Rev. Immunol."},{"key":"2025032411481937500_r48","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0092-8674(00)80059-8","article-title":"CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs","volume":"99","author":"F\u00f6rster","year":"1999","journal-title":"Cell"},{"key":"2025032411481937500_r49","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/nri2297","article-title":"CCR7 and its ligands: balancing immunity and tolerance","volume":"8","author":"F\u00f6rster","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"2025032411481937500_r50","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1126\/science.1070238","article-title":"Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists","volume":"296","author":"Mandala","year":"2002","journal-title":"Science"},{"key":"2025032411481937500_r51","doi-asserted-by":"crossref","first-page":"5037","DOI":"10.4049\/jimmunol.160.10.5037","article-title":"FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats, I: FTY720 selectively decreases the number of circulating mature lymphocytes by acceleration of lymphocyte homing","volume":"160","author":"Chiba","year":"1998","journal-title":"J. Immunol."},{"key":"2025032411481937500_r52","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.pharmthera.2005.05.002","article-title":"FTY720, a new class of immunomodulator, inhibits lymphocyte egress from secondary lymphoid tissues and thymus by agonistic activity at sphingosine 1-phosphate receptors","volume":"108","author":"Chiba","year":"2005","journal-title":"Pharmacol. Ther."},{"key":"2025032411481937500_r53","doi-asserted-by":"crossref","first-page":"288","DOI":"10.4161\/mabs.1.3.8527","article-title":"Specificity tuning of antibody fragments to neutralize two human chemokines with a single agent","volume":"1","author":"Fag\u00e8te","year":"2009","journal-title":"mAbs"},{"key":"2025032411481937500_r54","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0165-2478(97)00075-8","article-title":"Effect of a CC chemokine receptor antagonist on collagen induced arthritis in DBA\/1 mice","volume":"57","author":"Plater-Zyberk","year":"1997","journal-title":"Immunol. Lett."},{"key":"2025032411481937500_r55","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1002\/art.21033","article-title":"Amelioration of rat adjuvant-induced arthritis by Met-RANTES","volume":"52","author":"Shahrara","year":"2005","journal-title":"Arthritis Rheum."},{"key":"2025032411481937500_r56","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1084\/jem.186.1.131","article-title":"An antagonist of monocyte chemoattractant protein 1 (MCP-1) inhibits arthritis in the MRL-lpr mouse model","volume":"186","author":"Gong","year":"1997","journal-title":"J. Exp. Med."},{"key":"2025032411481937500_r57","doi-asserted-by":"crossref","first-page":"890","DOI":"10.4049\/jimmunol.172.2.890","article-title":"Dual role of CCR2 during initiation and progression of collagen-induced arthritis: evidence for regulatory activity of CCR2+ T cells","volume":"172","author":"Br\u00fchl","year":"2004","journal-title":"J. Immunol."},{"key":"2025032411481937500_r58","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1172\/JCI200420126","article-title":"Experimental arthritis in CC chemokine receptor 2-null mice closely mimics severe human rheumatoid arthritis","volume":"113","author":"Quinones","year":"2004","journal-title":"J. Clin. Invest."},{"key":"2025032411481937500_r59","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1002\/art.21975","article-title":"A randomized controlled trial with an anti-CCL2 (anti-monocyte chemotactic protein 1) monoclonal antibody in patients with rheumatoid arthritis","volume":"54","author":"Haringman","year":"2006","journal-title":"Arthritis Rheum."}],"container-title":["The Journal of Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/185\/4\/2544\/61610901\/1000182.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/185\/4\/2544\/61610901\/1000182.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T23:15:45Z","timestamp":1743203745000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jimmunol\/article\/185\/4\/2544\/7977689"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":59,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,8,15]]}},"URL":"https:\/\/doi.org\/10.4049\/jimmunol.1000182","relation":{},"ISSN":["0022-1767","1550-6606"],"issn-type":[{"type":"print","value":"0022-1767"},{"type":"electronic","value":"1550-6606"}],"subject":[],"published-other":{"date-parts":[[2010,8]]},"published":{"date-parts":[[2010,8]]}}}